{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:39:02Z","timestamp":1794551942067,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04429-5","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T14:13:13Z","timestamp":1759759993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clazosentan for cerebral vasospasm prevention in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Saaed","family":"Abunada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taimoor","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasnain Ali","family":"Moryani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partab","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiya","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muskan","family":"Turesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shah","family":"Dev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Hyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Aizazuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sateesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laksh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidra","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih Abdella","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"4429_CR1","doi-asserted-by":"crossref","unstructured":"Ran KR, Wang AC, Nair SK, Ak\u00e7a O, Xu R. Acute Multidisciplinary Management of Aneurysmal Subarachnoid Hemorrhage (aSAH). Balkan Med J. 2023;40(2):74\u201381. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36883719\/.\u00a0[cited 2025 Mar 16].","DOI":"10.4274\/balkanmedj.galenos.2023.2023-1-100"},{"key":"4429_CR2","doi-asserted-by":"crossref","unstructured":"Belavadi R, Gudigopuram SVR, Raguthu CC, Gajjela H, Kela I, Kakarala CL et al. Surgical Clipping Versus Endovascular Coiling in the Management of Intracranial Aneurysms. Cureus. 2021;13(12). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35047297\/.\u00a0[cited 2025 Mar 16].","DOI":"10.7759\/cureus.20478"},{"key":"4429_CR3","doi-asserted-by":"crossref","unstructured":"Li K, Barras CD, Chandra RV, Kok HK, Maingard JT, Carter NS et al. A Review of the Management of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2019;126:513\u201327. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30898740\/.\u00a0[cited 2025 Mar 16].","DOI":"10.1016\/j.wneu.2019.03.083"},{"key":"4429_CR4","doi-asserted-by":"crossref","unstructured":"Foreman B. The pathophysiology of delayed cerebral ischemia. Journal of Clinical Neurophysiology. 2016;33(3):174\u201382. Available from: https:\/\/journals.lww.com\/clinicalneurophys\/fulltext\/2016\/06000\/the_pathophysiology_of_delayed_cerebral_ischemia.2.aspx.\u00a0[cited 2025 Mar 16].","DOI":"10.1097\/WNP.0000000000000273"},{"key":"4429_CR5","doi-asserted-by":"crossref","unstructured":"Luzzi S, Bekta\u015fo\u011flu PK, Do\u011fruel Y, G\u00fcngor A. Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia. Neurosurgical Review 2024;47(1):1\u201319. Available from:\u00a0https:\/\/link.springer.com\/article\/.\u00a0[cited 2025 Mar 16].","DOI":"10.1007\/s10143-024-02543-5"},{"key":"4429_CR6","doi-asserted-by":"crossref","unstructured":"Hougaard A, Younis S, Iljazi A, Haanes KA, Lindberg U, Vestergaard MB et al. Cerebrovascular effects of endothelin-1 investigated using high-resolution magnetic resonance imaging in healthy volunteers. J Cereb Blood Flow Metab. 2020;40(8):1685\u201394. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31500524\/.\u00a0[cited 2025 Mar 16].","DOI":"10.1177\/0271678X19874295"},{"key":"4429_CR7","doi-asserted-by":"crossref","unstructured":"Juif PE, Dingemanse J, Ufer M. Clinical Pharmacology of clazosentan, a selective [internet]ndothelin A [internet]eceptor antagonist for [internet]he prevention and [internet]reatment of aSAH-Related cerebral vasospasm. Front Pharmacol. 2021;11:628956. Available from: www.frontiersin.org.\u00a0[cited 2025 Mar 28].","DOI":"10.3389\/fphar.2020.628956"},{"key":"4429_CR8","doi-asserted-by":"crossref","unstructured":"MacDonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39(11):3015\u201321. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18688013\/.\u00a0[cited 2025 Mar 16].","DOI":"10.1161\/STROKEAHA.108.519942"},{"key":"4429_CR9","doi-asserted-by":"crossref","unstructured":"Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10(7):618\u201325. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21640651\/.\u00a0[cited 2024 Sep 8].","DOI":"10.1016\/S1474-4422(11)70108-9"},{"key":"4429_CR10","doi-asserted-by":"crossref","unstructured":"MacDonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A et al. Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials. Neurocrit Care. 2010;13(3):416\u201324. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20838933\/.\u00a0[cited 2025 Mar 16].","DOI":"10.1007\/s12028-010-9433-3"},{"key":"4429_CR11","doi-asserted-by":"crossref","unstructured":"Raja S, Raja A, Shuja MH, Ali A. Clazosentan\u2019s dual edge in managing vasospasm following aneurysmal subarachnoid hemorrhage: an updated systematic review, meta-analysis, and meta-regression of clinical outcomes and safety profiles. Neurosurg Rev. 2025;48(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39753744\/.\u00a0[cited 2025 Mar 16].","DOI":"10.1007\/s10143-024-03173-7"},{"key":"4429_CR12","doi-asserted-by":"crossref","unstructured":"Ikawa F, Morita A, Nakayama T, Goto Y, Sakai N, Iihara K et al. A register-based SAH study in Japan: high incidence rate and recent decline trend based on lifestyle. J Neurosurg. 2020;134(3):983\u201391. Available from: https:\/\/thejns.org\/view\/journals\/j-neurosurg\/134\/3\/article-p983.xml.\u00a0[cited 2025 Mar 16].","DOI":"10.3171\/2020.1.JNS192848"},{"key":"4429_CR13","doi-asserted-by":"crossref","unstructured":"Al-Salihi MM, Saha R, Abd Elazim A, Helal A, Sabah Al-Jebur M, Al-Salihi Y et al. The effectiveness and safety of clazosentan in treating aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis. Journal of Clinical Neuroscience. 2024;126:173\u201381. Available from: http:\/\/www.jocn-journal.com\/article\/S0967586824002571\/fulltext.\u00a0[cited 2024 Dec 12].","DOI":"10.1016\/j.jocn.2024.06.019"},{"key":"4429_CR14","doi-asserted-by":"crossref","unstructured":"Kajiwara S, Kawano T, Hasegawa Y, Nakamura Y, Sakata K, Kikuchi J et al. Impact of Clazosentan on Vasospasm Reduction and Functional Recovery after Aneurysmal Subarachnoid Hemorrhage. Neurol Med Chir (Tokyo). 2025;65(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39581616\/.\u00a0[cited 2025 Mar 27].","DOI":"10.2176\/jns-nmc.2024-0204"},{"key":"4429_CR15","doi-asserted-by":"crossref","unstructured":"Okumura E, Nakaya K, Otsuka K, Jimbo H. Treatment Outcomes of Clazosentan Use During the Perioperative Period for Subarachnoid Hemorrhage. Cureus. 2025;17(2). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/40135022\/.\u00a0[cited 2025 Mar 27].","DOI":"10.7759\/cureus.79497"},{"key":"4429_CR16","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int J Surg. 2021;88. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33789826\/.\u00a0[cited 2024 Jun 30]."},{"key":"4429_CR17","doi-asserted-by":"crossref","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31462531\/.\u00a0[cited 2024 Jun 30].","DOI":"10.1136\/bmj.l4898"},{"key":"4429_CR18","doi-asserted-by":"crossref","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20652370\/.\u00a0[cited 2025 Mar 26].","DOI":"10.1007\/s10654-010-9491-z"},{"key":"4429_CR19","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12958120\/.\u00a0[cited 2024 Jun 30].","DOI":"10.1136\/bmj.327.7414.557"},{"key":"4429_CR20","doi-asserted-by":"crossref","unstructured":"Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F et al. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg. 2005;103(1):9\u201317. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16121967\/.\u00a0[cited 2024 Sep 8].","DOI":"10.3171\/jns.2005.103.1.0009"},{"key":"4429_CR21","doi-asserted-by":"crossref","unstructured":"MacDonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A et al. Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke. 2012;43(6):1463\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22403047\/.\u00a0[cited 2024 Sep 8].","DOI":"10.1161\/STROKEAHA.111.648980"},{"key":"4429_CR22","doi-asserted-by":"crossref","unstructured":"Fujimura M, Joo JY, Kim JS, Hatta M, Yokoyama Y, Tominaga T. Preventive Effect of Clazosentan against Cerebral Vasospasm after Clipping Surgery for Aneurysmal Subarachnoid Hemorrhage in Japanese and Korean Patients. Cerebrovasc Dis. 2017;44(1\u20132):59\u201367. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28463833\/.\u00a0[cited 2024 Sep 8].","DOI":"10.1159\/000475824"},{"key":"4429_CR23","doi-asserted-by":"crossref","unstructured":"Endo H, Hagihara Y, Kimura N, Takizawa K, Niizuma K, Togo O et al. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients. J Neurosurg. 2022;137(6):1707\u201317. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35364589\/.\u00a0[cited 2024 Sep 8].","DOI":"10.3171\/2022.2.JNS212914"},{"key":"4429_CR24","doi-asserted-by":"crossref","unstructured":"Maeda T, Okawara M, Osakabe M, Yamaguchi H, Maeda T, Kurita H. Initial real-world experience of clazosentan for subarachnoid hemorrhage in Japan. World Neurosurg X. 2023;21. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38090191\/.\u00a0[cited 2025 Mar 26].","DOI":"10.1016\/j.wnsx.2023.100253"},{"key":"4429_CR25","unstructured":"Mayer SA, Bruder N, Citerio G, Defreyne L, Dubois C, Gupta R et al. REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2024;1\u201312. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39126720\/.\u00a0[cited 2024 Sep 8]."},{"key":"4429_CR26","doi-asserted-by":"crossref","unstructured":"Mochizuki T, Ryu B, Shima S, Kamijyo E, Ito K, Ando T et al. Comparison of efficacy between clazosentan and fasudil hydrochloride-based management of vasospasm after subarachnoid hemorrhage focusing on older and WFNS grade V patients: a single-center experience in Japan. Neurosurg Rev. 2024;47(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38472507\/.\u00a0[cited 2025 Mar 26].","DOI":"10.1007\/s10143-024-02345-9"},{"issue":"2","key":"4429_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.hest.2023.11.006","volume":"5","author":"H Maeda","year":"2024","unstructured":"Maeda H, Izumo T, Okamura K, Yamaguchi S, Morofuji Y, Matsuo T. Evolving approaches in the management of patients with subarachnoid hemorrhage from 2002 to 2022: the impact of Clazosentan and treatment modalities on outcomes. Brain Hemorrhages. 2024;5(2):55\u201361.","journal-title":"Brain Hemorrhages"},{"key":"4429_CR28","doi-asserted-by":"crossref","unstructured":"Lai A, Tan CO, Vranic J, Weidauer S, Leslie-Mazwi T, Hirsch JA et al. Clazosentan for Improvement of Time to Peak Perfusion in Patients with Angiographically Confirmed Severe Vasospasm. Neurocrit Care. 2022;36(1):240\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34296399\/.\u00a0[cited 2025 Mar 26].","DOI":"10.1007\/s12028-021-01291-4"},{"key":"4429_CR29","doi-asserted-by":"crossref","unstructured":"Pontes JPM, Santos MDC, Gibram FC, Rodrigues NMV, Cavalcante-Neto JF, Barros ADM et al. Efficacy and Safety of Clazosentan After Aneurysmal Subarachnoid Hemorrhage: An Updated Meta-Analysis. Neurosurgery. 2023;93(6):1208\u201319. Available from: https:\/\/journals.lww.com\/neurosurgery\/fulltext\/2023\/12000\/efficacy_and_safety_of_clazosentan_after.2.aspx.\u00a0[cited 2025 Mar 28].","DOI":"10.1227\/neu.0000000000002601"},{"key":"4429_CR30","doi-asserted-by":"crossref","unstructured":"D\u2019Souza S. Aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol. 201524;27(3):222\u201340. Available from: https:\/\/journals.lww.com\/jnsa\/fulltext\/2015\/07000\/aneurysmal_subarachnoid_hemorrhage.6.aspx.","DOI":"10.1097\/ANA.0000000000000130"},{"key":"4429_CR31","doi-asserted-by":"crossref","unstructured":"Pearl JD, MacDonald RL. Vasospasm after aneurysmal subarachnoid hemorrhage: need for further study. Acta Neurochir Suppl (Wien). 2008;(105):207\u201310. Available from:\u00a0https:\/\/link.springer.com\/chapter\/.\u00a0[cited 2025 Mar 28].","DOI":"10.1007\/978-3-211-09469-3_39"},{"key":"4429_CR32","doi-asserted-by":"crossref","unstructured":"Wang X, Li YM, Li WQ, Huang CG, Lu YC, Hou LJ. Effect of Clazosentan in Patients with Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials. PLoS One. 2012;7(10):e47778. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0047778.\u00a0[cited 2025 Mar 29].","DOI":"10.1371\/journal.pone.0047778"},{"key":"4429_CR33","doi-asserted-by":"crossref","unstructured":"Hu P, Yan T, Li Y, Guo G, Gao X, Su Z et al. Effect of Surgical Clipping versus Endovascular Coiling on the Incidence of Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Multicenter Observational Cohort Study with Propensity Score Matching. World Neurosurg. 2023;172:e378\u201388. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36657714\/.\u00a0[cited 2024 Sep 9].","DOI":"10.1016\/j.wneu.2023.01.032"},{"key":"4429_CR34","doi-asserted-by":"crossref","unstructured":"Treggiari MM, Rabinstein AA, Busl KM, Caylor MM, Citerio G, Deem S et al. Guidelines for the Neurocritical Care Management of Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care. 2023;39(1):1\u201328. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37202712\/.\u00a0[cited 2025 Aug 23].","DOI":"10.1007\/s12028-023-01713-5"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04429-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04429-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04429-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T14:13:19Z","timestamp":1759759999000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04429-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4429"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04429-5","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not involve human participants or require ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"No individual data requiring consent for publication is included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"413"}}